Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Stomach Neoplasms 4Carcinoma, Hepatocellular 3Solid Tumor 2Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Turcot syndrome 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Cancer Resectable 1Pancreatic Cancer Metastatic 1Neoplasms 1Multiple Primary Lung Cancer 1Metastatic Gastroesophageal Junction Adenocarcinoma 1Melanoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Cervical Carcinoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Advanced Solid Tumours 1Advanced Solid Tumor 1Advanced Intrahepatic Cholangiocarcinoma 1Advanced Biliary Tract Cancer 1Adenocarcinoma 1

Interventions

toripalimab 2pembrolizumab 2tislelizumab 1spartalizumab 1sintilimab 1camrelizumab 1Taxes 1Cyclophosphamide 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Locally Advanced or Metastatic Solid Tumors × sintilimab × Clear all
NCT05699811 2023-04-28

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

Chinese PLA General Hospital

Phase 1/2 Recruiting
40 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡